COLLEGE PARK, MD - New research at the A. James Clark School of Engineering could prevent bacterial infections using tiny biochemical machines-nanofactories-that can confuse bacteria and stop them from spreading, without the use of antibiotics.
We remember reading Dr. K. Eric Drexler’s 1986 book, “The Engines of Creation,” which suggested that eventually medicine might develop submicroscopic factories much like this to battle disease on a molecular level. Drexler’s ideas about the atomic-sized machines sounded like science fiction at the time.
But this research brings his ideas startlingly to life.
A paper about the research is featured in the current issue of Nature Nanotechnology.
The work is an update on the researchers’ original nanofactories, first developed in 2007. Those nanofactories made use of tiny magnetic bits to guide them to the infection site.
Nanofactories recognize good from bad bacteria
William Bentley, professor and chair, Fischell Department of Bioengineering at the Clark School says “This is a completely new, all-biological version. The new nanofactories are self-guided and targeted.”
Bentley advised the research group, which included Clark School alumnus Rohan Fernandes (Ph.D. ’08, bioengineering), graduate student Varnika Roy (molecular and cell biology), and graduate student Hsuan-Chen Wu (bioengineering).
The new nanofactories can tell the difference between bad (pathogenic) and good bacteria. For instance, our digestive tracts contain a certain level of good bacteria to help us digest food. The new nanofactories could target just the bad bacteria, without disrupting the levels of good bacteria in the digestive tract (a common side effect of many antibiotics). Nanofactories target the bacteria directly rather than traveling throughout the body, another advantage over traditional antibiotics.
Bacterial cells talk to each other in a form of cell-to-cell communication known as quorum sensing. When the cells sense that they have reached a certain quantity, an infection could be triggered. The biological nanofactories developed at the Clark School can interrupt this communication, disrupting the actions of the cells and shutting down an infection.
Alternatively, the nanofactories could trick the bacteria into sensing a quorum too early. Doing so would trigger the bacteria to try to form an infection before there are enough bacterial cells to do harm. This would prompt a natural immune system response capable of stopping them without the use of drugs.
Because nanofactories are designed to affect communication instead of trying to kill the bacteria, they could help treat illness in cases where a strain of bacteria has become resistant to antibiotics.
May have other benefits
The nanofactories’ ability to alter cell-to-cell communication isn’t limited to fighting infections.
“Quorum sensing and signaling molecules are actually used to accomplish a lot of things,” Bentley explains. “Sometimes disease develops because communication is not taking place-a good example is digestive disorders that involve an imbalance of bacteria in the digestive tract. In that case, nanofactories could be used to start or increase communication instead of disrupting it.”
“The work by Dr. Bentley is extremely exciting as he is using the ability of engineering to “build” using nature based components,” says Philip Leduc, associate professor in the Departments of Mechanical and Biomedical Engineering at Carnegie Mellon University. “Understanding the science of cells is wonderful, but then using these components and constructing systems that leverage biological advantages is a huge step forward.”
Read the article at Nature Nanotechnology (http://www.nature.com/nnano/journal/vaop/ncurrent/full/nnano.2009.457.html)
Visit Professor Bentley’s web site (http://www.bioe.umd.edu/~bentley/)
See a research overview at the Biochip Collaborative web site (http://biochip.umd.edu/bentley/index.html)
- GlaxoSmithKline gets $41M DOD contract to develop new antibiotics
- NC State researchers home in on ways to fight antibiotic resistant infections
- New Nanotech school opens in Greensboro
- Johns Hopkins research could lead to new type of antibiotics
- Biochip microfactories could speed drug development
© 2010, TechJournal. All rights reserved.